Gabrielle Ghabash1, Jacob Wilkes2, Bradley J Barney3, Joshua L Bonkowsky4. 1. University of Utah School of Medicine, Salt Lake City, UT, USA. 2. Intermountain Healthcare, Salt Lake City, UT, USA. 3. Division of Critical Care, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. 4. Division of Pediatric Neurology, Primary Children's Center for Personalized Medicine, Primary Children's Hospital, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA.
Abstract
OBJECTIVE: The purpose of our study was to understand the healthcare burden and incidence of Krabbe disease (Krabbe). METHODS: Retrospective analysis of Krabbe patients identified October 1, 2015 through December 31, 2020, ages birth through age 3, evaluated in two national databases. We estimated point prevalence and incidence from year 2016 data. RESULTS: We identified 98 unique Krabbe patients with 736 visits including 260 were inpatient admissions. Total healthcare charges were $51.5 million dollars. We determined a point prevalence of 34 68 Krabbe patients in 2016 ages 0 3 years. This estimates a birth incidence of ~1 in 310,000 live births. Significance: Krabbe disease patients had over $51 million in health care charges and hundreds of hospitalizations. Estimated prevalence and birth incidence is similar to rates observed from newborn screening. Our findings show the tremendous health impacts of Krabbe disease, and provide guidance for efforts in screening and treatment planning.
OBJECTIVE: The purpose of our study was to understand the healthcare burden and incidence of Krabbe disease (Krabbe). METHODS: Retrospective analysis of Krabbe patients identified October 1, 2015 through December 31, 2020, ages birth through age 3, evaluated in two national databases. We estimated point prevalence and incidence from year 2016 data. RESULTS: We identified 98 unique Krabbe patients with 736 visits including 260 were inpatient admissions. Total healthcare charges were $51.5 million dollars. We determined a point prevalence of 34 68 Krabbe patients in 2016 ages 0 3 years. This estimates a birth incidence of ~1 in 310,000 live births. Significance: Krabbe disease patients had over $51 million in health care charges and hundreds of hospitalizations. Estimated prevalence and birth incidence is similar to rates observed from newborn screening. Our findings show the tremendous health impacts of Krabbe disease, and provide guidance for efforts in screening and treatment planning.
Authors: Carlos A Saavedra-Matiz; Paola Luzi; Matthew Nichols; Joseph J Orsini; Michele Caggana; David A Wenger Journal: J Neurosci Res Date: 2016-11 Impact factor: 4.164
Authors: Haille E Soderholm; Alexander B Chapin; Pinar Bayrak-Toydemir; Joshua L Bonkowsky Journal: Pediatr Neurol Date: 2020-06-17 Impact factor: 3.372
Authors: Nadav I Weinstock; Daesung Shin; Narayan Dhimal; Xinying Hong; Eric E Irons; Nicholas J Silvestri; Chelsey B Reed; Duc Nguyen; Oliver Sampson; Yung-Chih Cheng; Joseph T Y Lau; Ernesto R Bongarzone; Julia Kofler; Maria L Escolar; Michael H Gelb; Lawrence Wrabetz; M Laura Feltri Journal: Neuron Date: 2020-05-05 Impact factor: 17.173
Authors: Adam J Guenzel; Coleman T Turgeon; Kim K Nickander; Amy L White; Dawn S Peck; Gisele B Pino; April L Studinski; Vinod K Prasad; Joanne Kurtzberg; Maria L Escolar; Maria Laura Duque Lasio; Joan E Pellegrino; Ai Sakonju; Rachel E Hickey; Natalie M Shallow; Margie A Ream; Joseph J Orsini; Michael H Gelb; Kimiyo Raymond; Dimitar K Gavrilov; Devin Oglesbee; Piero Rinaldo; Silvia Tortorelli; Dietrich Matern Journal: Genet Med Date: 2020-02-24 Impact factor: 8.822
Authors: Joseph J Orsini; Denise M Kay; Carlos A Saavedra-Matiz; David A Wenger; Patricia K Duffner; Richard W Erbe; Chad Biski; Monica Martin; Lea M Krein; Matthew Nichols; Joanne Kurtzberg; Maria L Escolar; Darius J Adams; Georgianne L Arnold; Alejandro Iglesias; Patricia Galvin-Parton; David F Kronn; Jennifer M Kwon; Paul A Levy; Joan E Pellegrino; Natasha Shur; Melissa P Wasserstein; Michele Caggana Journal: Genet Med Date: 2016-01-21 Impact factor: 8.822